Validation of pain catastrophizing scale on breast cancer survivor

Pérez‐Cruzado, David; Roldán-Jiménez, Cristina; Iglesias‐Campos, Marcos; Pajares, Bella; Alba, Emilio; Cuesta‐Vargas, Antonio

doi:10.1111/papr.13163

Cited by 8 publications

(3 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We also examined the convergent validity of FACS, by assessing its relationship with the PCS. In previous studies, the Spanish version showed a moderate correlation with the PCS (r = 0.49 to 0.53) [ 39 , 41 ], and the Serbian and Turkish versions showed a high correlation (r = 0.77 and r = 0.68 respectively) [ 14 , 40 ]. The high correlation between the FACS-Fr/CF and PCS-CF (r = 0.72; p < 0.005) was very close to the Serbian and Turkish versions.…”

Section: Discussionmentioning

confidence: 99%

Cross-cultural translation and psychometric validation of the French version of the Fear-Avoidance Components Scale (FACS)

Duport,

Bédard,

Raynauld

et al. 2023

PLoS ONE

View full text Add to dashboard Cite

Background The Fear-Avoidance Components Scale (FACS) is a reliable and valid instrument widely used to assess fear-avoidance beliefs related to pain and disability. However, there is a scarcity of validated translations of the FACS in different cultural and linguistic contexts, including the French population. This study aimed to translate and validate the French version of the FACS (FACS-Fr/CF), examining its psychometric properties among French-speaking individuals. Methods A cross-cultural translation process–including forward translation, backward translation, expert committee review, and pre-testing–was conducted to develop the FACS-Fr/CF. The translated version was administered to a sample of French-speaking adults (n = 55) with chronic musculoskeletal pain. Internal consistency (including confirmatory analyses of the 2 factors identified in the Serbian version), test-retest reliability and convergent validity were then assessed. Results The FACS-Fr/CF demonstrated high global internal consistency (α = 0.94, 95% CI: 0.91–0.96) as well as high internal consistency of the 2 factors identified in the Serbian version (α = 0.90, 95% CI: 0.86–0.94 and α = 0.90, 95% CI: 0.85–0.94, respectively). Test-retest analysis revealed a moderate (close to high) reliability (ICC = 0.89; 95% CI: 0.82–0.94 and r = 0.89; p<0.005). Convergent validity was supported by significant correlations between the FACS-Fr/CF scores and the Tampa Scale for Kinesiophobia (r = 0.82; p < 0.005), the Pain Catastrophizing Scale (r = 0.72; p < 0.005) and the Hospital Anxiety and Depression Scale (r = 0.66; p < 0.005). Conclusion The present study provides evidence for the cross-cultural translation and psychometric validation of the FACS-Fr/CF. The FACS-Fr/CF exhibits a high internal consistency, a moderate (close to high) test-retest reliability, and good construct validity, suggesting its utility in assessing fear-avoidance beliefs in the French-speaking population. This validated tool can enhance the assessment and understanding of fear-avoidance behaviors and facilitate cross-cultural research in pain-related studies.

show abstract

Section: Discussionmentioning

confidence: 99%

Cross-cultural translation and psychometric validation of the French version of the Fear-Avoidance Components Scale (FACS)

Duport,

Bédard,

Raynauld

et al. 2023

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…Pain catastrophizing was ascertained using the Pain Catastrophizing Scale (PCS), the sum of 13 items indicating the degree they experience thoughts and feelings that occur during pain episodes on a 5-point scale with 0 (not at all) to 4 (all the time) 33 . In the sample, the PCS demonstrated good internal consistency ( α = .93).…”

Section: Methodsmentioning

confidence: 99%

The Contribution of Cancer-Specific Psychosocial Factors to the Pain Experience in Cancer Survivors

Jones

Magee

et al. 2023

J Hosp Palliat Nurs

View full text Add to dashboard Cite

Palliative care teams are increasingly called up to manage chronic pain in cancer survivors. Chronic pain is common in cancer survivors and is heavily influenced by biopsychosocial factors. This study aimed to determine the relative contribution of unique cancer-specific psychosocial factors, pain catastrophizing, and multisite pain to the pain experience in 41 cancer survivors who completed curative cancer treatment. To test the research hypotheses, a series of nested linear regression models were used with likelihood ratio testing to test the individual and collective contribution of cancer-specific psychosocial factors (fear of cancer recurrence, cancer distress, cancer-related trauma), pain catastrophizing, and the number of pain sites on the pain experience. The results indicate pain catastrophizing and multisite pain explained a significant degree of variance in pain interference scores (P < .001) and pain severity (P = .005). Cancer-specific psychosocial factors did not significantly predict variability in pain interference (P = .313) or pain severity (P = .668) over and above pain catastrophizing and the number of sites of pain. In summary, pain catastrophizing and multisite pain contribute to the chronic cancer-related pain experienced by cancer survivors. Palliative care nurses are well positioned to improve chronic pain among cancer survivors by assessing and treating pain catastrophizing and multisite pain.

show abstract

“…Pain is one of the most feared and persistent clinical symptoms of cancer, which can occur in people at an early stage, but also several years after survival or cessation of treatment. It is estimated that up to 30% of women with breast cancer suffer from chronic pain, even ten years after treatment [5]. The prevalence of cancer pain is high, so it should not be underestimated and should be addressed from the beginning of its course, not only if it is severe, because patients suffering from pain respond less well to cancer treatment.…”

Section: Introductionmentioning

confidence: 99%

Effect of Non-Pharmacological Treatment on Pain in Women With Breast Cancer

Obročníková,

Majerníková,

Hudáková

2024

hpc

View full text Add to dashboard Cite

Pain is the most dreaded symptom of breast cancer that significantly affects the patient's quality of life. The aim of this article was to present non-pharmacological interventions used to effectively manage pain in breast cancer patients. This is a review article; studies were researched in the PubMed database. Using the keywords: non-pharmacological AND intervention AND pain AND breast cancer OR breast neoplasms, 6 relevant studies were selected that met the specified criteria on non-pharmacological interventions for pain relief in women with breast cancer. Yoga, acupuncture and electroacupuncture in women with breast cancer appear to be promising non-pharmacological interventions in pain reduction. Other studies on cognitivebehavioral therapy and massage therapies have similarly demonstrated significant reductions in pain in women with breast cancer, whether induced by systemic therapy, hormone therapy, or surgery. Non-pharmacological interventions have been shown to be an appropriate adjunctive alternative in the management of pain in cancer patients, but can be applied alongside standard pharmacological treatment under professional supervision to improve the patient's quality of life.

show abstract

Validation of pain catastrophizing scale on breast cancer survivor

Cited by 8 publications

References 47 publications

Cross-cultural translation and psychometric validation of the French version of the Fear-Avoidance Components Scale (FACS)

Cross-cultural translation and psychometric validation of the French version of the Fear-Avoidance Components Scale (FACS)

The Contribution of Cancer-Specific Psychosocial Factors to the Pain Experience in Cancer Survivors

Effect of Non-Pharmacological Treatment on Pain in Women With Breast Cancer

Contact Info

Product

Resources

About